Bullish option flow detected in Cytokinetics with 2,666 calls trading, 1.7x expected, and implied vol increasing over 6 points to 107.16%. Dec-23 40 calls and Nov-23 40 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.15. Earnings are expected on November 2nd.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CYTK:
- CYTK Earnings this Week: How Will it Perform?
- Cytokinetics call volume above normal and directionally bullish
- Cytokinetics price target lowered to $48 from $54 at JPMorgan
- Cytokinetics rumor mentioned by Betaville blog
- Morgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth Prospects